Woodline Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
5,584
+1,756
+46% +$376K ﹤0.01% 897
2026
Q1
$846K Sell
3,828
-12,924
-77% -$3.16M ﹤0.01% 904
2025
Q4
$4.25M Buy
16,752
+3,735
+29% +$938K 0.02% 662
2025
Q3
$3.22M Buy
13,017
+2,390
+22% +$572K 0.02% 656
2025
Q2
$2.55M Buy
10,627
+2,327
+28% +$542K 0.01% 688
2025
Q1
$1.88M Buy
8,300
+2,372
+40% +$522K 0.01% 676
2024
Q4
$1.22M Buy
+5,928
New +$1.3M 0.01% 732
2023
Q4
Sell
-28,318
Closed -$6.21M 647
2023
Q3
$6.21M Sell
28,318
-29,316
-51% -$6.63M 0.07% 285
2023
Q2
$13M Buy
57,634
+44,104
+326% +$8.83M 0.15% 174
2023
Q1
$2.59M Buy
+13,530
New +$2.62M 0.04% 386

Other funds holding STE

Woodline Partners's STE Position: Q2 2026 in Review

Woodline Partners increased its Steris (STE) stake by 46% in Q2 2026, buying an estimated $376K and bringing the position to 5,584 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Woodline Partners first reported a position in STE in Q1 2023 and has held it in 10 quarters since. The position peaked at $13M in Q2 2023. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Woodline Partners held 5,584 shares of Steris worth $1.18M as of Q2 2026.
  • Woodline Partners bought 1,756 Steris shares in Q2 2026, an estimated $376K.
  • Steris made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #897 holding.
  • Woodline Partners first reported a position in Steris in Q1 2023 and has held it in 10 quarters since.
  • Woodline Partners's Steris position peaked at $13M in Q2 2023.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.